Occult lobular breast cancer first discovered through colon metastases

This breast cancer diagnosis at a glance

Stage at diagnosis
Stage IV
Subtype
Invasive Lobular Carcinoma
Biomarkers
ER-positive; PR-negative; HER2-negative; E-cadherin-negative
Sex
Female
Spread to
colon
Treatment
hormone therapy and targeted therapy
Outcome
In Memory

Treatment course, step by step

  1. Letrozole hormone therapy.
  2. Palbociclib targeted therapy, intermittently held during acute illnesses.

What happened, in summary

A 73-year-old woman with chronic watery diarrhoea came to hospital with worsening abdominal symptoms, confusion, low blood pressure, and hypoglycaemia. Colonoscopy was performed after infectious stool studies were negative. Several polyps were benign tubular adenomas, but random biopsies from the colonic mucosa showed malignant cells consistent with metastatic invasive lobular breast carcinoma. The cells were oestrogen-receptor positive, progesterone-receptor negative, HER2 negative, and E-cadherin negative, supporting a breast lobular origin rather than a primary colorectal cancer. Her CA 27.29 tumour marker was elevated at 188. Mammography and breast ultrasound showed dense tissue but no identifiable primary breast lesion, and further breast MRI was not pursued because it would not change systemic treatment. The cancer was therefore managed as occult metastatic breast cancer presenting in the colon. She started letrozole and palbociclib. During follow-up, CA 27.29 fluctuated near baseline before falling to 136. Her course was complicated by repeated urinary tract infections and one admission for C. difficile colitis after antibiotics. Palbociclib had to be held several times during these acute illnesses. Imaging and tumour-marker monitoring continued to assess disease burden. Two years after the diagnosis, she developed urosepsis and died. Her case illustrates how lobular breast cancer can first appear through gastrointestinal metastases even when breast imaging does not reveal a primary tumour.

Where this story comes from

This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full

How we source and attribute stories Accuracy and limitations

Collections this story belongs to

Similar breast cancer stories

These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer

Search more breast cancer stories